MAIA
Maia Biotechnology Inc
Description:
MAIA Biotechnology Inc. is a pioneering biotechnology firm dedicated to the advancement of innovative cancer therapies that significantly enhance patient outcomes across various cancer types. Leveraging its proprietary technology platforms, the company focuses on developing novel drug candidates that stimulate the immune system to effectively combat tumors, addressing critical unmet medical needs in oncology. With a robust pipeline and a commitment to improving the treatment landscape, MAIA positions itself as a vital contributor to the biopharmaceutical industry, with substantial growth potential in the expanding healthcare market.
Address:
444 WEST LAKE STREET, CHICAGO, IL, UNITED STATES, 60606
Fiscal year end:
December
Market capitalization:
$85.9 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
4 years:
-46%
How much will you get:
$540
Prices dates:
28-07-2022: $4.46 and 30-01-2026: $2.41